• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 39-53 of 186 results

2015 Exhibit: Discovery of a D 2 Deoxy 2 C methyluridine Nucleotide Prodrug PSI 7...

Document IPR2018-00123, No. 2015-26 Exhibit - Discovery of a D 2 Deoxy 2 C methyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2002 Exhibit: Curing Chronic Hepatitis C The Arc of a Medical Triumph

Document IPR2018-00123, No. 2002-15 Exhibit - Curing Chronic Hepatitis C The Arc of a Medical Triumph (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2007 Exhibit: Americas Overspend How the Pharmaceutical Patent Problem is Fue...

Document IPR2018-00123, No. 2007-20 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2011 Exhibit: FDA Approves Pill to Treat Hepatitis C

Document IPR2018-00123, No. 2011-24 Exhibit - FDA Approves Pill to Treat Hepatitis C (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2004 Exhibit: HARVONI¿¿ label

Document IPR2018-00123, No. 2004-17 Exhibit - HARVONI¿¿ label (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2021 Exhibit: Synergy of Small Molecular Inhibitors of Hepatitis C Virus Replication...

Document IPR2018-00123, No. 2021-30 Exhibit - Synergy of Small Molecular Inhibitors of Hepatitis C Virus Replication Directed at Multiple Viral Targets (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2007 Exhibit: America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fu...

Document IPR2018-00123, No. 2007-20 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2006 Exhibit: Clofarabine From Design to Approval

Document IPR2018-00123, No. 2006-19 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2012 Exhibit: FDA Approves Gilead¿¿¿s Hepatitis C Drug

Document IPR2018-00123, No. 2012-25 Exhibit - FDA Approves Gilead¿¿¿s Hepatitis C Drug (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2010 Exhibit: Hepatitis C Deserves the Attention

Document IPR2018-00123, No. 2010-23 Exhibit - Hepatitis C Deserves the Attention (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2001 Exhibit: Nucleoside Analog Inhibitors of Hepatitis C Virus Replication

Document IPR2018-00123, No. 2001-14 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2003 Exhibit: FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir

Document IPR2018-00123, No. 2003-16 Exhibit - FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2008 Exhibit: I MAK Our People

Document IPR2018-00123, No. 2008-21 Exhibit - I MAK Our People (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze

2017 Exhibit: Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools f...

Document IPR2018-00123, No. 2017-27 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Mar. 19, 2...

cite Cite Document
Analyze

2009 Exhibit: Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infe...

Document IPR2018-00123, No. 2009-22 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Mar. 19, 2018)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 ... 11 12 13 >>